250 related articles for article (PubMed ID: 17277122)
1. Bacterial c-di-GMP is an immunostimulatory molecule.
Karaolis DK; Means TK; Yang D; Takahashi M; Yoshimura T; Muraille E; Philpott D; Schroeder JT; Hyodo M; Hayakawa Y; Talbot BG; Brouillette E; Malouin F
J Immunol; 2007 Feb; 178(4):2171-81. PubMed ID: 17277122
[TBL] [Abstract][Full Text] [Related]
2. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
[TBL] [Abstract][Full Text] [Related]
3. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells.
Means TK; Hayashi F; Smith KD; Aderem A; Luster AD
J Immunol; 2003 May; 170(10):5165-75. PubMed ID: 12734364
[TBL] [Abstract][Full Text] [Related]
4. Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia.
Karaolis DK; Newstead MW; Zeng X; Hyodo M; Hayakawa Y; Bhan U; Liang H; Standiford TJ
Infect Immun; 2007 Oct; 75(10):4942-50. PubMed ID: 17646358
[TBL] [Abstract][Full Text] [Related]
5. c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection.
Ogunniyi AD; Paton JC; Kirby AC; McCullers JA; Cook J; Hyodo M; Hayakawa Y; Karaolis DK
Vaccine; 2008 Aug; 26(36):4676-85. PubMed ID: 18640167
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
[TBL] [Abstract][Full Text] [Related]
7. Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities.
Gray PM; Forrest G; Wisniewski T; Porter G; Freed DC; DeMartino JA; Zaller DM; Guo Z; Leone J; Fu TM; Vora KA
Cell Immunol; 2012; 278(1-2):113-9. PubMed ID: 23121983
[TBL] [Abstract][Full Text] [Related]
8. c-di-GMP (3'-5'-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formation.
Karaolis DK; Rashid MH; Chythanya R; Luo W; Hyodo M; Hayakawa Y
Antimicrob Agents Chemother; 2005 Mar; 49(3):1029-38. PubMed ID: 15728899
[TBL] [Abstract][Full Text] [Related]
9. The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant.
Chen W; Kuolee R; Yan H
Vaccine; 2010 Apr; 28(18):3080-5. PubMed ID: 20197136
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
[TBL] [Abstract][Full Text] [Related]
11. Cyclic nucleotides promote monocyte differentiation toward a DC-SIGN+ (CD209) intermediate cell and impair differentiation into dendritic cells.
Giordano D; Magaletti DM; Clark EA; Beavo JA
J Immunol; 2003 Dec; 171(12):6421-30. PubMed ID: 14662841
[TBL] [Abstract][Full Text] [Related]
12. Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells.
Nakahara T; Uchi H; Urabe K; Chen Q; Furue M; Moroi Y
Int Immunol; 2004 Dec; 16(12):1701-9. PubMed ID: 15477228
[TBL] [Abstract][Full Text] [Related]
13. Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A.
Narita K; Hu DL; Mori F; Wakabayashi K; Iwakura Y; Nakane A
Infect Immun; 2010 Oct; 78(10):4234-42. PubMed ID: 20679443
[TBL] [Abstract][Full Text] [Related]
14. Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell-penetrating peptide or combined with CpG.
Yildiz S; Alpdundar E; Gungor B; Kahraman T; Bayyurt B; Gursel I; Gursel M
Eur J Immunol; 2015 Apr; 45(4):1170-9. PubMed ID: 25581346
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Synthesis of Cyclic-di-GMP Using a Recombinant Adenovirus Preferentially Improves Adaptive Immune Responses against Extracellular Antigens.
Alyaqoub FS; Aldhamen YA; Koestler BJ; Bruger EL; Seregin SS; Pereira-Hicks C; Godbehere S; Waters CM; Amalfitano A
J Immunol; 2016 Feb; 196(4):1741-52. PubMed ID: 26792800
[TBL] [Abstract][Full Text] [Related]
16. Cyclic-di-GMP stimulates keratinocyte innate immune responses and attenuates methicillin-resistant Staphylococcus aureus colonization in a murine skin wound infection model.
Gao S; Khan A; Chen X; Xiao G; van der Veen S; Chen Y; Lin X
BMC Microbiol; 2022 Jul; 22(1):176. PubMed ID: 35804301
[TBL] [Abstract][Full Text] [Related]
17. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells.
Gouwy M; Struyf S; Leutenez L; Pörtner N; Sozzani S; Van Damme J
Immunobiology; 2014 Mar; 219(3):218-29. PubMed ID: 24268109
[TBL] [Abstract][Full Text] [Related]
18. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells.
Seubert A; Monaci E; Pizza M; O'Hagan DT; Wack A
J Immunol; 2008 Apr; 180(8):5402-12. PubMed ID: 18390722
[TBL] [Abstract][Full Text] [Related]
19. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways.
Lin YL; Liang YC; Tseng YS; Huang HY; Chou SY; Hseu RS; Huang CT; Chiang BL
J Leukoc Biol; 2009 Oct; 86(4):877-89. PubMed ID: 19498044
[TBL] [Abstract][Full Text] [Related]
20. A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy.
Miyabe H; Hyodo M; Nakamura T; Sato Y; Hayakawa Y; Harashima H
J Control Release; 2014 Jun; 184():20-7. PubMed ID: 24727060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
